F 0644
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Coordinate assessments with the pre-admission screening and resident review program; and referring for
services as needed.
Based on interview, record reviews, and facility policy review, the facility failed to ensure a Preadmission
Screening and Resident Review (PASARR) Level I Screening was updated to reflect the presence of newly
diagnosed serious mental disorders for 1 (Resident #67) of 3 residents reviewed for PASARR requirements.
Findings included:
A facility policy titled, Resident Assessment - Coordination with PASARR Program, reviewed/revised
05/2024, revealed, This facility coordinates assessments with the preadmission screening and Resident
review (PASARR) program under Medicaid to ensure that individuals with a mental disorder, intellectual
disability, or a related condition receives care and services in the most integrated setting appropriate to
their needs. The policy specified, 9. Any Resident who exhibits a newly evident or possible serious mental
disorder, intellectual disability, or a related condition will be referred promptly to the state mental health or
intellectual disability authority for a level Il Resident review.
Resident #67's admission Record indicated the facility admitted the resident on 12/01/2023. According to
the admission Record, the resident had a medical history that included diagnoses of post-traumatic stress
disorder (PTSD) (onset date 12/04/2023), anxiety disorder (onset date 02/20/2024), and unspecified
psychosis not due to a substance or known physiological condition (onset date 05/21/2024).
Resident #67's care plan included a focus area, initiated 02/21/2024, that indicated the resident had a
mood problem related to a diagnosis of PTSD.
A quarterly Minimum Data Set (MDS), with an Assessment Reference Date (ARD) of 02/09/2025, revealed
Resident #67 had short- and long-term memory problems and severely impaired cognitive skills for daily
decision-making per a Staff Assessment of Mental Status (SAMS). According to the MDS, at the time of the
assessment, the resident had active diagnoses that included anxiety disorder, psychotic disorder, and
PTSD.
Resident #67's Level I PASARR Screening, dated 11/30/2023, revealed Section III- Serious Mental Illness,
question 10, was answered no to indicate the resident did not have a serious diagnosed mental disorder
such as depressive disorder, anxiety disorder, panic disorder, schizophrenia/schizoaffective disorder, or
symptoms of psychosis, delusions and/or mood disturbance. The Level I PASARR screening indicated the
screening was Negative, due to No Serious Mental Illness, and a Level II evaluation was Not Required.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
056048
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056048
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/20/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Pacific Coast Manor
1935 Wharf Road
Capitola, CA 95010
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0644
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Resident #67's medical record revealed no documented evidence a new Level I PASARR Screening was
completed after the addition of new mental illness diagnoses, including additions of PTSD in 12/2023,
anxiety disorder in 02/2024, and psychosis in 05/2024.
During an interview on 02/19/2025 at 10:12 AM, the Director of Resident Assessment (DRA) stated
Resident #67 had diagnoses that indicated there was a need for a new Level I Screening.
During an interview on 02/19/2025 at 1:58 PM, the DRA stated she was unable to find another PASARR for
Resident #67, aside from the one completed at the time of the resident's admission to the facility.
During an interview on 02/20/2025 at 8:12 AM, the Executive Director (ED) stated Resident #67 should
have had another PASARR submitted when their condition changed and new diagnoses were added.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056048
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056048
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/20/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Pacific Coast Manor
1935 Wharf Road
Capitola, CA 95010
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
Based on observation, interview, record review, and facility policy review, the facility failed to ensure
medications were securely stored for a resident deemed safe to self-administer medications for 1 (Resident
#247) of 1 resident reviewed for secure storage of self-administered medications.
Findings included:
A facility policy titled, Resident Self-Administration of Medication, reviewed/revised 06/26/2024, specified, 7.
Bedside medication storage is permitted only when it does not present a risk to confused residents who
wander into other resident's [sic] rooms or to confused roommates of the resident who self-administers
medications. The following conditions are met for bedside storage to occur: a. The manner of storage
prevents access by other residents. Lockable drawers and cabinets are required only if locked storage is
ineffective. b. The medications provided to the resident for bedside storage are kept in containers dispensed
by the provider pharmacy.
An admission Record indicated the facility admitted Resident #247 on 01/31/2025.
An admission Minimum Data Set (MDS), with an Assessment reference Date (ARD) of 02/06/2025,
revealed Resident #247 had a Brief Interview for Mental Status (BIMS) score of 14, which indicated the
resident was cognitively intact.
A Self-Administration of Medication assessment, dated 02/18/2025, indicated the facility determined
Resident #247 was fully capable of self-administering their inhaler and storing their medication in a secure
location.
Resident #247's Order Summary Report contained an order dated 02/18/2025 for albuterol sulfate
hydrofluoroalkane (HFA, a propellant used in some metered-dose inhalers) inhalation aerosol solution to be
administered every four hours as needed for shortness of breath (SOB). The Order Summary Report also
contained an order dated 02/18/2025 that indicated Resident #247 May self administer Albuterol inhaler.
Resident #247's Care Plan Report included a focus area, initiated 02/18/2025, that indicated the resident
had a physician's order for unsupervised self-administration of their prescribed albuterol inhaler.
An observation on 02/19/2025 at 11:15 AM revealed Resident #247's albuterol inhaler was in an open,
zippered bag on the resident's bedside table in their room. The bag had no locking mechanism. Resident
#247 shared a room with two other residents, and at the time of the observation, Resident #247 was
observed sitting outside their room in an outdoor courtyard.
During a concurrent observation and interview on 02/19/2025 at 12:34 PM, Resident #247 was observed
lying in bed with their inhaler in an open, zippered bag beside them. Resident #247 said the facility had not
offered them a lockable container to store their inhaler in.
During an observation on 02/20/2025 at 8:50 AM, Resident #247 was lying in bed with an open, zippered
bag that contained their albuterol inhaler.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056048
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056048
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/20/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Pacific Coast Manor
1935 Wharf Road
Capitola, CA 95010
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
During an interview on 02/19/2025 at 1:52 PM, Case Manager (CM) #3 said residents could keep a
medication at their bedside and self-administer if they had a physician's order to do so. CM #3 said the
medication would usually be stored in the bedside table, or the resident should have a lockbox to store the
medication in.
During an interview on 02/19/2025 at 2:01 PM, Registered Nurse (RN) #4 said if a resident requested to
self-administer a medication, the resident had to be assessed and their physician had to approve
self-administration. RN #4 said if a resident was approved to self-administer and store their medication at
the bedside, the resident should have a lockbox in their room to use for medication storage.
During an interview on 02/20/2025 at 10:05 AM, RN #6 stated she was assigned to care for Resident #247.
RN #6 said Resident #247 had orders to keep their inhaler in their room but the inhaler should be stored in
a drawer or other lockable storage area to prevent other residents from accessing it. RN #6 said they did
not know where Resident #247 was storing their inhaler. RN #6 said they would check and went to
Resident #247's room and noted the bedside drawers were not lockable and that the inhaler was not in a
bedside drawer. RN #6 confirmed the resident's inhaler was being kept in an unzipped bag with no lock in
the resident's room.
During an interview on 02/20/2025 at 10:28 AM, the Director of Nursing (DON) said Resident #247 had
their inhaler in their room, and the inhaler was being kept in a bag with a zipper. The DON said they had
lockboxes to provide to residents but did not think Resident #247 had been offered one. The DON said they
thought a bag with a zipper was secure. When asked about the facility policy pertaining to
self-administration of medications, the DON said they read the policy when they provided it to the surveyor
and noted it mentioned the use of locked storage for medications.
During an interview on 02/20/2025 at 10:49 AM, the Executive Director (ED) stated medications kept in
residents' rooms should be stored in an area that was not accessible to other residents, but accessible to
the resident for whom the medication was prescribed. The ED said if a medication was kept in a resident's
room, it should be stored in a lockbox to prevent other residents from accessing the medication.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056048
If continuation sheet
Page 4 of 4